Overactive MYC helps tumors fix DNA breaks and resist chemotherapy, study finds
medicalxpress - A protein best known for driving cancer growth also helps damaged tumor cells survive by repairing their DNA, according to a new study that could influence how some cancers are treated.
AI Summary: New research reveals overactive MYC drives tumor cells to repair DNA breaks more efficiently, enabling resistance to chemotherapy. By illuminating the repair pathways MYC hijacks, the study identifies potential targets to reverse resistance and improve treatment responses — because apparently cancers read the manual on how to survive your best shot.
- MYC hijacks DNA repair to enable chemo resistance (4)
- Other molecular drivers of chemoresistance and genome instability (3)
- Tumor cell death and immunity shape chemotherapy outcomes (3)
- All Other Stories
MYC hijacks DNA repair to enable chemo resistance
Other molecular drivers of chemoresistance and genome instability
Tumor cell death and immunity shape chemotherapy outcomes
All Other Stories
Related Stories
Mass release of next‑generation tumor organoids accelerates research / 22 days
Some tumors kill neighboring healthy cells to fuel growth / 2 months
Enhertu (DESTINY‑Lung04) improves PFS in HER2‑mutant lung cancer / 6 days
Engineered bacteria show promise as tumor‑targeting therapy in preclinical studies / 5 wks
Daraxonrasib shows encouraging activity in NRAS-driven melanoma patients / 6 wks
St. Jude pins RBM5 as a leukemia driver and therapeutic target / 6 wks
CAR‑T depletes mutant calreticulin cells, offering myelofibrosis hope / 1 month
StackHealth RSS
You can now follow topics by RSS - browse the complete list of topics, people, and organizations. Or, try Pfizer, Drug Development, Nutrition, Price Transparency and look for the RSS link.
StackHealth Time Machine